Mammalian Target of Rapamycin Promotes Vincristine Resistance through Multiple Mechanisms Independent of Maintained Glycolytic Rate
David James VanderWeele(Northwestern University), Charles M. Rudin(Memorial Sloan Kettering Cancer Center)
Cited by 20
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
|New England Journal of Medicine|2009|1k
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
|Cancer Cell|2020|398
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|312
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
|Journal of Thoracic Oncology|2019|307